blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2089034

EP2089034 - NOVEL USES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.09.2018
Database last updated on 05.10.2024
FormerGrant of patent is intended
Status updated on  13.12.2017
FormerExamination is in progress
Status updated on  15.11.2016
Most recent event   Tooltip21.09.2018Application deemed to be withdrawnpublished on 24.10.2018  [2018/43]
Applicant(s)For all designated states
Intra-Cellular Therapies, Inc.
430 East 29th Street, Suite 900
New York, NY 10016 / US
[2016/33]
Former [2009/34]For all designated states
Intra-Cellular Therapies, Inc.
3960 Broadway
New York, NY 10032 / US
Inventor(s)01 / FIENBERG, Allen A.
3960 Broadway
New York, NY 10032 / US
02 / WENNOGLE, Lawrence P.
3960 Broadway
New York, NY 10032 / US
03 / MATES, Sharon
3960 Broadway
New York, NY 10032 / US
 [2009/34]
Representative(s)Chapman, Paul Gilmour, et al
Marks & Clerk LLP
40 Torphichen Street
Edinburgh EH3 8JB / GB
[N/P]
Former [2013/42]Chapman, Paul Gilmour, et al
Marks & Clerk LLP
Atholl Exchange
6 Canning Street
Edinburgh EH3 8EG / GB
Former [2009/34]Chapman, Paul Gilmour, et al
Marks & Clerk LLP Aurora 120 Bothwell Street Glasgow
G2 7JS / GB
Application number, filing date07853247.005.12.2007
[2009/34]
WO2007US24866
Priority number, dateUS20060873104P05.12.2006         Original published format: US 873104 P
[2009/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008070095
Date:12.06.2008
Language:EN
[2008/24]
Type: A1 Application with search report 
No.:EP2089034
Date:19.08.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 12.06.2008 takes the place of the publication of the European patent application.
[2009/34]
Search report(s)International search report - published on:US12.06.2008
(Supplementary) European search report - dispatched on:EP25.06.2010
ClassificationIPC:A61K31/00, A61K31/495, A61K31/519, A61K31/565, A61K31/57, A61K9/00
[2017/46]
CPC:
A61K31/495 (EP,US); A61K31/00 (EP,US); A61K31/519 (EP,US);
A61K31/565 (EP,US); A61K31/57 (EP,US); A61P13/08 (EP);
A61P15/00 (EP); A61P15/06 (EP); A61P15/08 (EP);
A61P15/10 (EP); A61P15/12 (EP); A61P19/10 (EP);
A61P25/00 (EP); A61P35/00 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P5/14 (EP); A61P5/30 (EP) (-)
C-Set:
A61K31/519, A61K2300/00 (EP,US);
A61K31/565, A61K2300/00 (US,EP);
A61K31/57, A61K2300/00 (US,EP)
Former IPC [2010/30]A61K31/495, A61K31/519, A61K31/565, A61K31/57, A61K9/00
Former IPC [2009/34]A61K31/495
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/34]
TitleGerman:NEUE VERWENDUNGSZWECKE[2009/34]
English:NOVEL USES[2009/34]
French:NOUVELLES UTILISATIONS[2009/34]
Entry into regional phase16.06.2009National basic fee paid 
16.06.2009Search fee paid 
16.06.2009Designation fee(s) paid 
16.06.2009Examination fee paid 
Examination procedure16.06.2009Examination requested  [2009/34]
20.01.2011Amendment by applicant (claims and/or description)
20.04.2011Despatch of a communication from the examining division (Time limit: M04)
25.08.2011Reply to a communication from the examining division
04.06.2013Despatch of a communication from the examining division (Time limit: M06)
12.12.2013Reply to a communication from the examining division
07.07.2016Despatch of a communication from the examining division (Time limit: M04)
14.11.2016Reply to a communication from the examining division
14.12.2017Communication of intention to grant the patent
25.04.2018Application deemed to be withdrawn, date of legal effect  [2018/43]
04.06.2018Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2018/43]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.04.2011
Fees paidRenewal fee
11.12.2009Renewal fee patent year 03
15.12.2010Renewal fee patent year 04
12.12.2011Renewal fee patent year 05
11.12.2012Renewal fee patent year 06
12.12.2013Renewal fee patent year 07
11.12.2014Renewal fee patent year 08
10.12.2015Renewal fee patent year 09
13.12.2016Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.12.201711   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP0201188  (WARNER LAMBERT CO [US]) [Y] 1,12,13,16-18 * the whole document *;
 [Y]WO9119717  (SCHERING CORP [US]) [Y] 1,8,12,13,16-18,20 * page 1, line 18 - page 3, line 21 * * page 75, lines 1-10 * * claims 1-9; compounds 1-56 *;
 [XYI]US2004259792  (PALMER STEPHEN S [US], et al) [X] 1,8,12,13,16 * paragraph [0118] * * paragraphs [0173] - [0176]; claims 14,16,17,18,19,26-29,32 * [Y] 2-7,17,18 [I] 19,20;
 [XP]WO2006133261  (INTRA CELLULAR THERAPIES INC [US], et al) [XP] 1-13,16-20 * the whole document *;
 [E]WO2007143705  (INTRA CELLULAR THERAPIES INC [US], et al) [E] 1-20 * the whole document *;
 [E]WO2008063505  (INTRA CELLULAR THERAPIES INC [US], et al) [E] 1-20* the whole document *;
 [Y]  - JIANG ET AL, "Chemoenzymatic Asymmetric Total Synthesis of Phosphodiesterase Inhibitors: Preparation of a Polycyclic Pyrazolo[3,4-d]pyrimidine from an Acylnitroso Diels-Alder Cycloadduct-Derived Aminocyclopentenol", JOURNAL OF ORGANIC CHEMISTRY , 70(7), 2824-2827 CODEN: JOCEAH; ISSN: 0022-3263,, (20050101), XP002578513 [Y] 1,2,4-13,16-20 * Figure 1, Scheme 6 *
 [Y]  - YAN XIA ET AL, "SYNTHESIS AND EVALUATION OF POLYCYCLIC PYRAZOLOÄ3,4-DÜPYRIMIDINES AS PDE1 AND PDE5 CGMP PHOSPHODIESTERASE INHIBITORS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US LNKD- DOI:10.1021/JM970495B, (19970101), vol. 40, no. 26, ISSN 0022-2623, pages 4372 - 4377, XP002166300 [Y] 1,2,4-13,16-20 * table 1 * * Chart 1, 2 *

DOI:   http://dx.doi.org/10.1021/jm970495b
 [Y]  - UECKERT STEFAN ET AL, "Detection of phosphodiesterase (PDE) isoenzymes 1, 2, 10 and 11 in the human clitoris by means of molecular biology and immunohistochemistry", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, (20040401), vol. 171, no. 4, Suppl, ISSN 0022-5347, page 428, XP009133665 [Y] 1-13,16-20 * abstract *
 [A]  - ALLENDE C ET AL, "Characterization of cyclic nucleotide phosphodiesterases in Xenopus laevis ovary", COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY. B. COMPARATIVEBIOCHEMISTRY, PERGAMON PRESS, LONDON, GB LNKD- DOI:10.1016/0305-0491(87)90348-8, vol. 88, no. 2, ISSN 0305-0491, (19870101), pages 581 - 587, (19870101), XP023529029 [A] 1-20 * page 586, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/0305-0491(87)90348-8
International search[Y]US5294612  (BACON EDWARD R [US], et al);
 [Y]US5939419  (TULSHIAN DEEN [US], et al);
 [X]US6235742  (BELL ANDREW SIMON [GB], et al);
 [Y]US6756373  (ALLERTON CHARLOTTE MOIRA NORFO [GB], et al);
 [Y]US6969719  (ASBEROM THEODROS [US], et al)
Examination   - AHN H-S ET AL, "POTENT TETRACYCLIC GUANINE INHIBITORS OF PDE1 AND PDE5 CYCLIC GUANOSINE MONOPHOSPHATE PHOSPHODIESTERASES WITH ORAL ANTIHYPERTENSIVE ACTIVITY", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19970101), vol. 40, no. 14, doi:10.1021/JM9608467, ISSN 0022-2623, pages 2196 - 2210, XP001120374

DOI:   http://dx.doi.org/10.1021/jm9608467
by applicantEP0201188
 US4666908
 EP0538332
 US5393755
 EP0911333
 US5939419
 US6235742
 WO03020702
 WO03042216
 US6943171
 US6969719
 WO2006US22066
 WO2006US33179
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.